Theravance Biopharma, Inc. (TBPH)

20.48 +0.90 (+4.60%) USD  |  NASDAQ  |  Feb 06, 16:00
20.46 -0.02 (-0.10%) After-Hours: 20:00
More

Theravance Biopharma Cash and Equivalents (Quarterly)

Cash and Equivalents (Quarterly) Chart

View Cash and Equivalents (Quarterly) for TBPH.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Cash and Equivalents (Quarterly) Chart
Start Trial

Historical Data

View Historical Data
Start Trial

Cash and Equivalents (Quarterly) Range, Past 5 Years

View Cash and Equivalents (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Cash and Equivalents (Quarterly) Benchmarks

View Cash and Equivalents (Quarterly) Benchmarks
Start Trial
Corcept Therapeutics, Inc. Upgrade
Nektar Therapeutics Upgrade
Innoviva, Inc. Upgrade
Oramed Pharmaceuticals, Inc. Upgrade
Skye Bioscience, Inc. Upgrade